Accurate assignment of disease liability to genetic variants using only population data
Joseph Michael CollacoiD, Karen S. RaraighiD, Joshua BetziD, Melis A. AksitiD, Nenad BlauiD, Jordan BrowniD, Harry C. DietziD, Gretchen L. MacCarrickiD, Lawrence M. NogeeiD, Molly B. Sheridan, Hilary J. VernoniD, Terri H. BeatyiD, Thomas A. LouisiD, Garry R. CuttingiD
Abstract
PurposeThe growing size of public variant repositories prompted us to test the accuracy of predicting pathogenicity of DNA variants using population data alone. MethodsUnder the a priori assumption that the ratio of the prevalence of variants in healthy and affected populations form two distinct distributions (pathogenic and benign), we used a Bayesian method to assign probability of a variant belonging to either distribution. ResultsThe approach, termed BayPR, accurately parsed 300 of 313 expertly curated cystic fibrosis transmembrane conductance regulator (CFTR) variants: 284 of 296 pathogenic/likely pathogenic (P/LP) variants in one distribution and 16 of 17 benign/likely benign (B/LB) variants in another. BayPR produced an area under the receiver operating curve (AUC) of 0.99 for 103 functionally-confirmed missense CFTR variants, equal to or exceeding ten commonly used algorithms (AUC range: 0.54 to 0.99). Application of BayPR to expertly curated variants in eight genes associated with seven Mendelian conditions assigned [≥]80% disease-causing probability to 1,350 of 1,374 (98.3%) P/LP variants and [≤]20% to 22 of 23 (95.7%) B/LB variants. ConclusionAgnostic to variant type or functional effect, BayPR provides probabilities of pathogenicity for DNA variants responsible for Mendelian disorders using only variant counts in affected and unaffected population samples.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 6
- FWCI
- 0.71
- Field percentile
- top 32%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A Bayesian method using sparse data to estimate penetrance of disease-associated genetic variants
Brett M. Kroncke, Derek K. Smith, … Jeffrey D. Blume·bioRxiv·Mar 7, 2019
- Quantifying prior probabilities for disease-causing variants reveals the top genetic contributors in inborn errors of immunity
Quant Group, Simon Boutry, … Dylan Lawless·medRxiv·Mar 25, 2025
- Beyond thresholds: a fully Bayesian framework for quantifying allele count evidence for variant pathogenicity
Fedor A. Konovalov·bioRxiv·Feb 10, 2026
- How good are pathogenicity predictors in detecting benign variants?
Abhishek Niroula, Mauno Vihinen·PLoS Computational BiologyPeer-reviewed·Feb 11, 2019
- Using high-resolution variant frequencies to empower clinical genome interpretation
Nicola Whiffin, Eric Vallabh Minikel, … James S. Ware·Genetics in MedicinePeer-reviewed·May 18, 2017
- Benchmarking AlphaMissense Pathogenicity Predictions Against Cystic Fibrosis Variants
Eli Fritz McDonald, Kathryn E. Oliver, … Lars Plate·PLoS ONEPeer-reviewed·Jan 25, 2024